Lifecare ASA - Director's Dealing 2026

Lifecare ASA: Mandatory notification of trade

The Company has been informed that Hannibal Invest AS, a company closely

associated with Hans Hekland, board member and primary insider of Lifecare

ASA, has sold 319,550 shares in the Company at an average price of NOK 0.374

per share. The shares have been sold to finance the exercise of warrants.

Following this transaction, Hannibal Invest AS holds 1,131,948 shares and

705,196 Warrants Series 2 in the Company.

About us

Lifecare ASA is a medical sensor company developing technology for sensing and

monitoring of various body analytes. Lifecare's focus is to bring the next

generation of Continuous Glucose Monitoring systems to market. Lifecare

enables osmotic pressure as sensing principle. Lifecare's sensor technology is

suitable for identifying and monitoring the occurrence of a wide range of

analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, [email protected], +47 40 05 90 40

Petter Nielsen, CFO, [email protected], +47 92 24 74 64

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR. The information was submitted for publication, through the

agency of the contact persons set out above, at 2026-05-19 22:03 CEST.

AI assistant